Characterizing tumor immune microenvironment (TME) and outcomes for 409 patients (pts) treated on COMPARZ: Distinct clusters emphasize immune infiltration vs. angiogenesis.

4515Background: Growing evidence highlights the critical role of the TME for RCC biology and response to systemic therapy. We used integrated molecular profiling to characterize immune & stromal TM...